Technetium labelled glucosamine ( DrugBank: Glucosamine )

---

2 diseases

ID	Disease name (Link within this page)	Number of trials
46	Malignant rheumatoid arthritis	1
271	Ankylosing spondylitis	1

46. Malignant rheumatoid arthritis

---

Clinical trials : 4,325 /  Drugs : 2,671 - (DrugBank : 417) / Drug target genes : 187 - Drug target pathways : 224

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT01789151 (ClinicalTrials.gov)	October 2012	7/2/2013	99m-Technetium- Glucosamine in Arthritis	99mTc-labelled D-Glucosamine in the Evaluation of Disease Activity in Patients With Degenerative and Inflammatory Rheumatic Conditions	Rheumatoid Arthritis;Ankylosing Spondylitis	Device: Technetium labelled glucosamine	University of Sydney	AbbVie	No longer available	18 Years	90 Years	Both		N/A	Australia

271. Ankylosing spondylitis

---

Clinical trials : 563 /  Drugs : 372 - (DrugBank : 72) / Drug target genes : 41 - Drug target pathways : 145

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT01789151 (ClinicalTrials.gov)	October 2012	7/2/2013	99m-Technetium- Glucosamine in Arthritis	99mTc-labelled D-Glucosamine in the Evaluation of Disease Activity in Patients With Degenerative and Inflammatory Rheumatic Conditions	Rheumatoid Arthritis;Ankylosing Spondylitis	Device: Technetium labelled glucosamine	University of Sydney	AbbVie	No longer available	18 Years	90 Years	Both		N/A	Australia